nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR2—pancreatic cancer	0.866	1	CbGaD
Vapreotide—Pasireotide—SSTR3—pancreatic cancer	0.00167	0.199	CrCbGaD
Vapreotide—Pasireotide—SSTR1—pancreatic cancer	0.00167	0.199	CrCbGaD
Vapreotide—Pasireotide—SSTR2—pancreatic cancer	0.00142	0.169	CrCbGaD
Vapreotide—Octreotide—SSTR1—pancreatic cancer	0.00124	0.148	CrCbGaD
Vapreotide—Octreotide—SSTR3—pancreatic cancer	0.00124	0.148	CrCbGaD
Vapreotide—Octreotide—SSTR2—pancreatic cancer	0.00106	0.126	CrCbGaD
Vapreotide—SSTR5—Signaling Pathways—HEY2—pancreatic cancer	9.81e-05	0.000783	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	9.78e-05	0.000781	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTHLH—pancreatic cancer	9.72e-05	0.000776	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—DTX4—pancreatic cancer	9.67e-05	0.000771	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GLI1—pancreatic cancer	9.67e-05	0.000771	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGTR1—pancreatic cancer	9.61e-05	0.000767	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GAST—pancreatic cancer	9.58e-05	0.000765	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CNR1—pancreatic cancer	9.47e-05	0.000756	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGTR1—pancreatic cancer	9.45e-05	0.000754	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NRP1—pancreatic cancer	9.4e-05	0.00075	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PPP2R5B—pancreatic cancer	9.4e-05	0.00075	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—SHH—pancreatic cancer	9.32e-05	0.000743	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IAPP—pancreatic cancer	9.2e-05	0.000734	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GCG—pancreatic cancer	9.14e-05	0.00073	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SCT—pancreatic cancer	9.08e-05	0.000725	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DTX1—pancreatic cancer	9.08e-05	0.000725	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SSTR3—pancreatic cancer	9.08e-05	0.000725	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HEY1—pancreatic cancer	9.08e-05	0.000725	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HEY2—pancreatic cancer	9.05e-05	0.000722	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—SST—pancreatic cancer	8.89e-05	0.00071	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GAST—pancreatic cancer	8.84e-05	0.000706	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTHLH—pancreatic cancer	8.83e-05	0.000705	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTCH1—pancreatic cancer	8.83e-05	0.000705	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	8.72e-05	0.000696	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGTR1—pancreatic cancer	8.72e-05	0.000696	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SSTR1—pancreatic cancer	8.71e-05	0.000695	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCK—pancreatic cancer	8.66e-05	0.000691	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PPY—pancreatic cancer	8.54e-05	0.000681	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CNR2—pancreatic cancer	8.44e-05	0.000674	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GLP1R—pancreatic cancer	8.44e-05	0.000674	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL8—pancreatic cancer	8.44e-05	0.000673	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SSTR2—pancreatic cancer	8.38e-05	0.000669	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SCT—pancreatic cancer	8.38e-05	0.000669	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HEY1—pancreatic cancer	8.38e-05	0.000669	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCKAR—pancreatic cancer	8.31e-05	0.000663	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—pancreatic cancer	8.21e-05	0.00979	CrCbGaD
Vapreotide—TACR1—GPCR downstream signaling—CNR1—pancreatic cancer	8.21e-05	0.000655	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCKBR—pancreatic cancer	8.1e-05	0.000646	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—SST—pancreatic cancer	8.08e-05	0.000645	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JAG2—pancreatic cancer	8.06e-05	0.000643	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	8.05e-05	0.000643	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCK—pancreatic cancer	8e-05	0.000638	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	7.95e-05	0.000634	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MEN1—pancreatic cancer	7.94e-05	0.000634	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GCG—pancreatic cancer	7.93e-05	0.000633	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CNR2—pancreatic cancer	7.79e-05	0.000622	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GLP1R—pancreatic cancer	7.79e-05	0.000622	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL8—pancreatic cancer	7.79e-05	0.000621	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	7.71e-05	0.000615	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCKAR—pancreatic cancer	7.67e-05	0.000612	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DTX4—pancreatic cancer	7.61e-05	0.000607	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GLI1—pancreatic cancer	7.61e-05	0.000607	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SHH—pancreatic cancer	7.57e-05	0.000604	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGTR1—pancreatic cancer	7.56e-05	0.000603	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH4—pancreatic cancer	7.53e-05	0.000601	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	7.51e-05	0.000599	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IAPP—pancreatic cancer	7.48e-05	0.000597	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CNR1—pancreatic cancer	7.45e-05	0.000595	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JAG2—pancreatic cancer	7.43e-05	0.000593	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PPP2R5B—pancreatic cancer	7.4e-05	0.000591	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NRP1—pancreatic cancer	7.4e-05	0.000591	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MEN1—pancreatic cancer	7.33e-05	0.000585	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GCG—pancreatic cancer	7.2e-05	0.000574	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTHLH—pancreatic cancer	7.18e-05	0.000573	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTCH1—pancreatic cancer	7.18e-05	0.000573	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HEY2—pancreatic cancer	7.13e-05	0.000569	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SHH—pancreatic cancer	6.99e-05	0.000558	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GAST—pancreatic cancer	6.96e-05	0.000556	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH4—pancreatic cancer	6.95e-05	0.000554	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IAPP—pancreatic cancer	6.9e-05	0.000551	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	6.9e-05	0.00055	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGTR1—pancreatic cancer	6.87e-05	0.000548	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTHLH—pancreatic cancer	6.63e-05	0.000529	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTCH1—pancreatic cancer	6.63e-05	0.000529	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SCT—pancreatic cancer	6.6e-05	0.000527	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HEY1—pancreatic cancer	6.6e-05	0.000527	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SST—pancreatic cancer	6.57e-05	0.000524	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.48e-05	0.000517	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JAG1—pancreatic cancer	6.43e-05	0.000513	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH3—pancreatic cancer	6.4e-05	0.000511	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	6.38e-05	0.000509	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCK—pancreatic cancer	6.3e-05	0.000502	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CNR2—pancreatic cancer	6.14e-05	0.00049	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GLP1R—pancreatic cancer	6.14e-05	0.00049	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL8—pancreatic cancer	6.13e-05	0.000489	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SST—pancreatic cancer	6.06e-05	0.000484	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CNR1—pancreatic cancer	6.06e-05	0.000484	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCKAR—pancreatic cancer	6.04e-05	0.000482	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.98e-05	0.000477	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JAG1—pancreatic cancer	5.93e-05	0.000473	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH3—pancreatic cancer	5.91e-05	0.000471	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CG—pancreatic cancer	5.88e-05	0.000469	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GCG—pancreatic cancer	5.85e-05	0.000467	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JAG2—pancreatic cancer	5.85e-05	0.000467	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MEN1—pancreatic cancer	5.77e-05	0.00046	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.69e-05	0.000454	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CNR1—pancreatic cancer	5.59e-05	0.000446	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGTR1—pancreatic cancer	5.58e-05	0.000446	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STK11—pancreatic cancer	5.5e-05	0.000439	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SHH—pancreatic cancer	5.5e-05	0.000439	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH4—pancreatic cancer	5.47e-05	0.000436	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IAPP—pancreatic cancer	5.43e-05	0.000434	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CG—pancreatic cancer	5.43e-05	0.000433	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GCG—pancreatic cancer	5.4e-05	0.000431	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.25e-05	0.000419	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTHLH—pancreatic cancer	5.22e-05	0.000416	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTCH1—pancreatic cancer	5.22e-05	0.000416	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CD—pancreatic cancer	5.17e-05	0.000413	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGTR1—pancreatic cancer	5.15e-05	0.000411	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STK11—pancreatic cancer	5.08e-05	0.000405	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.96e-05	0.000396	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SMAD4—pancreatic cancer	4.82e-05	0.000385	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.77e-05	0.000381	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SST—pancreatic cancer	4.77e-05	0.000381	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—pancreatic cancer	4.77e-05	0.000381	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HES1—pancreatic cancer	4.71e-05	0.000376	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.71e-05	0.000376	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JAG1—pancreatic cancer	4.67e-05	0.000373	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH3—pancreatic cancer	4.65e-05	0.000371	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.58e-05	0.000365	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CB—pancreatic cancer	4.51e-05	0.00036	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SMAD4—pancreatic cancer	4.45e-05	0.000355	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CNR1—pancreatic cancer	4.4e-05	0.000351	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.4e-05	0.000351	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HES1—pancreatic cancer	4.34e-05	0.000347	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—pancreatic cancer	4.33e-05	0.000346	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CG—pancreatic cancer	4.27e-05	0.000341	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GCG—pancreatic cancer	4.25e-05	0.000339	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CB—pancreatic cancer	4.16e-05	0.000332	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.14e-05	0.00033	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TERT—pancreatic cancer	4.12e-05	0.000329	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGTR1—pancreatic cancer	4.06e-05	0.000324	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STK11—pancreatic cancer	4e-05	0.000319	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—pancreatic cancer	4e-05	0.000319	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIF1A—pancreatic cancer	3.94e-05	0.000315	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSC2—pancreatic cancer	3.93e-05	0.000314	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOE—pancreatic cancer	3.85e-05	0.000307	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TERT—pancreatic cancer	3.81e-05	0.000304	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—pancreatic cancer	3.77e-05	0.000301	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.76e-05	0.0003	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIF1A—pancreatic cancer	3.64e-05	0.00029	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSC2—pancreatic cancer	3.63e-05	0.00029	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.61e-05	0.000288	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFKBIA—pancreatic cancer	3.59e-05	0.000286	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH1—pancreatic cancer	3.55e-05	0.000284	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOE—pancreatic cancer	3.55e-05	0.000284	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SMAD4—pancreatic cancer	3.5e-05	0.000279	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—pancreatic cancer	3.48e-05	0.000278	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CG—pancreatic cancer	3.47e-05	0.000277	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NRAS—pancreatic cancer	3.47e-05	0.000277	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—pancreatic cancer	3.47e-05	0.000277	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGF—pancreatic cancer	3.43e-05	0.000274	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HES1—pancreatic cancer	3.42e-05	0.000273	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFKBIA—pancreatic cancer	3.31e-05	0.000264	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH1—pancreatic cancer	3.28e-05	0.000262	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.27e-05	0.000261	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CG—pancreatic cancer	3.21e-05	0.000256	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NRAS—pancreatic cancer	3.21e-05	0.000256	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGF—pancreatic cancer	3.17e-05	0.000253	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EGFR—pancreatic cancer	3.17e-05	0.000253	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—pancreatic cancer	3.15e-05	0.000251	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CD—pancreatic cancer	3.05e-05	0.000244	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.03e-05	0.000241	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TERT—pancreatic cancer	3e-05	0.000239	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KRAS—pancreatic cancer	2.99e-05	0.000239	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EGFR—pancreatic cancer	2.92e-05	0.000233	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIF1A—pancreatic cancer	2.87e-05	0.000229	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSC2—pancreatic cancer	2.86e-05	0.000228	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CD—pancreatic cancer	2.82e-05	0.000225	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOE—pancreatic cancer	2.8e-05	0.000223	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.79e-05	0.000223	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KRAS—pancreatic cancer	2.76e-05	0.00022	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—pancreatic cancer	2.75e-05	0.000219	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—pancreatic cancer	2.74e-05	0.000219	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CB—pancreatic cancer	2.66e-05	0.000212	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFKBIA—pancreatic cancer	2.61e-05	0.000208	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH1—pancreatic cancer	2.58e-05	0.000206	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—pancreatic cancer	2.56e-05	0.000204	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HRAS—pancreatic cancer	2.54e-05	0.000203	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.54e-05	0.000202	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CG—pancreatic cancer	2.52e-05	0.000201	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NRAS—pancreatic cancer	2.52e-05	0.000201	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGF—pancreatic cancer	2.5e-05	0.000199	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—pancreatic cancer	2.47e-05	0.000197	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CB—pancreatic cancer	2.46e-05	0.000196	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP3—pancreatic cancer	2.45e-05	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCND1—pancreatic cancer	2.38e-05	0.00019	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—pancreatic cancer	2.36e-05	0.000188	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNB1—pancreatic cancer	2.36e-05	0.000188	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HRAS—pancreatic cancer	2.35e-05	0.000187	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—pancreatic cancer	2.31e-05	0.000185	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTEN—pancreatic cancer	2.3e-05	0.000184	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EGFR—pancreatic cancer	2.3e-05	0.000184	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—pancreatic cancer	2.28e-05	0.000182	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP3—pancreatic cancer	2.26e-05	0.00018	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—pancreatic cancer	2.24e-05	0.000179	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CD—pancreatic cancer	2.22e-05	0.000177	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCND1—pancreatic cancer	2.2e-05	0.000176	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.2e-05	0.000175	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNB1—pancreatic cancer	2.18e-05	0.000174	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KRAS—pancreatic cancer	2.17e-05	0.000173	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—pancreatic cancer	2.14e-05	0.00017	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SRC—pancreatic cancer	2.13e-05	0.00017	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTEN—pancreatic cancer	2.12e-05	0.000169	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—pancreatic cancer	2.08e-05	0.000166	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—pancreatic cancer	2.07e-05	0.000165	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—pancreatic cancer	2.06e-05	0.000164	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NRAS—pancreatic cancer	2.05e-05	0.000164	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—pancreatic cancer	2e-05	0.000159	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SRC—pancreatic cancer	1.97e-05	0.000157	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.93e-05	0.000154	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—pancreatic cancer	1.92e-05	0.000153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—pancreatic cancer	1.91e-05	0.000153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—pancreatic cancer	1.91e-05	0.000152	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—pancreatic cancer	1.9e-05	0.000152	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NRAS—pancreatic cancer	1.89e-05	0.000151	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGFR—pancreatic cancer	1.87e-05	0.000149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—pancreatic cancer	1.86e-05	0.000148	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HRAS—pancreatic cancer	1.85e-05	0.000147	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—pancreatic cancer	1.8e-05	0.000143	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP3—pancreatic cancer	1.78e-05	0.000142	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KRAS—pancreatic cancer	1.77e-05	0.000141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—pancreatic cancer	1.76e-05	0.000141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—pancreatic cancer	1.76e-05	0.00014	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCND1—pancreatic cancer	1.73e-05	0.000138	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGFR—pancreatic cancer	1.73e-05	0.000138	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.71e-05	0.000137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—pancreatic cancer	1.68e-05	0.000134	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTEN—pancreatic cancer	1.67e-05	0.000133	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—pancreatic cancer	1.63e-05	0.00013	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KRAS—pancreatic cancer	1.63e-05	0.00013	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—pancreatic cancer	1.62e-05	0.00013	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—pancreatic cancer	1.57e-05	0.000125	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SRC—pancreatic cancer	1.55e-05	0.000124	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—pancreatic cancer	1.51e-05	0.00012	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HRAS—pancreatic cancer	1.5e-05	0.00012	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—pancreatic cancer	1.5e-05	0.00012	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—pancreatic cancer	1.49e-05	0.000119	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NRAS—pancreatic cancer	1.49e-05	0.000119	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—pancreatic cancer	1.45e-05	0.000116	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—pancreatic cancer	1.39e-05	0.000111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—pancreatic cancer	1.39e-05	0.000111	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HRAS—pancreatic cancer	1.39e-05	0.000111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGFR—pancreatic cancer	1.36e-05	0.000108	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—pancreatic cancer	1.33e-05	0.000106	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KRAS—pancreatic cancer	1.28e-05	0.000102	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—pancreatic cancer	1.22e-05	9.76e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.18e-05	9.41e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—pancreatic cancer	1.14e-05	9.1e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HRAS—pancreatic cancer	1.09e-05	8.71e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—pancreatic cancer	9.63e-06	7.69e-05	CbGpPWpGaD
